Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 6 clinical trials for: Urothelial,Bladder cancer, 150 miles

2 trials recruiting
Be6A Clinical Trials
Evaluating sigvotatug vedotin to see if it will extend life expectancy and increase the period before cancer recurs.
  • Bladder Cancer
  • Recruiting
View studies
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
  • Bladder Cancer
  • Recruiting
NCT07566156
Sex: All
Age: 18+
Locations: 9
View study
Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
  • Bladder Cancer
  • Recruiting
NCT07421700
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
  • Bladder Cancer
  • Recruiting
NCT04389632
Sex: All
Age: 18+
Locations: 159
View study
Recruiting
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
  • Bladder Cancer
  • Recruiting
NCT07206225
Sex: All
Age: 18+
Locations: 47
View study
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
  • Bladder Cancer
  • Recruiting
NCT04879329
Sex: All
Age: 18+
Locations: 223
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
  • Bladder Cancer
  • Recruiting
NCT07090499
Sex: All
Age: 18+
Locations: 28
View study